Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05233436
Title PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
HonorHealth Scottsdale Shea Medical Center Scottsdale Arizona 85260 United States Details
D&H Cancer Research Center LLC Margate Florida 33063 United States Details
Napa Research Margate Florida 33063 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Mary Crowley Cancer Research - Medical City Hospital Dallas Texas 75230 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio Texas 78229 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
The Cancer Institute Hospital of JFCR Koto Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field